|Bid||14.37 x 800|
|Ask||20.25 x 800|
|Day's Range||19.07 - 19.58|
|52 Week Range||12.27 - 22.99|
|Beta (3Y Monthly)||-0.16|
|PE Ratio (TTM)||200.82|
|Earnings Date||Oct 29, 2019 - Nov 4, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||19.28|
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Today we'll look at Materialise NV (NASDAQ:MTLS) and reflect on its potential as an investment. In particular, we'll...
Materialise (MTLS) delivered earnings and revenue surprises of -125.00% and 1.03%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Materialise (MTLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
A look at the shareholders of Materialise NV (NASDAQ:MTLS) can tell us which group is most powerful. Generally...
Sigma Labs, Inc. (SGLB) (“Sigma Labs”), a provider of quality assurance software, and Materialise NV (MTLS), a leading provider of additive manufacturing software and 3D printing solutions, signed a non-binding Memorandum of Understanding to cooperate in integration of the Materialise MCP Controller with Sigma Labs’s PrintRite3D technology. Combining the sophisticated control technology with in-situ process monitoring for metal additive manufacturing will give customers maximal control on the production process, allowing them to become even more productive. The two companies are partnering to integrate this inspection tool with the Materialise Control Platform (MCP).
TVT2019 – Structural Heart Summit -- Materialise (MTLS), a global 3D printing software and solutions company, has received FDA clearance for its Mimics Enlight cardiovascular planning software suite. The first release will support clinicians planning complex transcatheter mitral valve replacement (TMVR) procedures. Mimics Enlight is based on the strengths of Materialise’s Mimics Innovation Suite, which has helped clinicians produce patient-specific 3D models for more than 20 years.
HP (HPQ) launches Jet Fusion 5200 printer and new partnership program, expands collaborations with key companies to boost presence in 3D printing market.
Materialise (MTLS) delivered earnings and revenue surprises of -200.00% and -1.07%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
The Levuen, Belgium-based company said it had a loss of 1 cent per share. The 3D printing software and medical and industrial products company posted revenue of $52.9 million in the period. Materialise ...
Materialise NV , a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the first quarter ended March 31, 2019.
While small-cap stocks, such as Materialise NV (NASDAQ:MTLS) with its market cap of US$859m, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downtu...
Materialise NV , a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the first quarter ended March 31, 2019 on Tuesday, April 30, 2019 at 6:30 a.m.
Materialise NV , a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the full year and fourth quarter ended December 31, 2018.
NEW YORK, NY / ACCESSWIRE / March 6, 2019 / Materialise NV Sponsored ADR (NASDAQ: MTLS ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 6, 2019 at 8:30 ...